昭衍新药
(603127)
| 流通市值：208.94亿 | | | 总市值：248.38亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2025-08-18 | 2596.82万 | 2.56% | -7059.65万 | -6.96% | -2075.79万 | -2.05% | 6538.62万 | 6.44% |
| 2025-08-15 | -433.45万 | -0.47% | -678.58万 | -0.74% | 967.36万 | 1.06% | 144.67万 | 0.16% |
| 2025-08-14 | -10176.35万 | -6.80% | -724.62万 | -0.48% | 1006.41万 | 0.67% | 9894.55万 | 6.61% |
| 2025-08-13 | 19920.29万 | 11.25% | 2752.09万 | 1.55% | -8315.43万 | -4.70% | -14356.95万 | -8.11% |
| 2025-08-12 | -953.91万 | -1.10% | -4163.94万 | -4.80% | 2296.56万 | 2.65% | 2821.30万 | 3.25% |
| 2025-08-11 | -1373.35万 | -1.42% | 5921.80万 | 6.13% | 2470.10万 | 2.56% | -7018.55万 | -7.27% |
| 2025-08-08 | 274.15万 | 0.38% | 668.00万 | 0.93% | -1844.86万 | -2.56% | 902.70万 | 1.25% |
| 2025-08-07 | -9977.57万 | -9.47% | -4853.63万 | -4.60% | -1046.47万 | -0.99% | 15877.67万 | 15.06% |
| 2025-08-06 | -4527.38万 | -3.68% | -10319.30万 | -8.38% | 6864.72万 | 5.57% | 7981.96万 | 6.48% |
| 2025-08-05 | -1229.01万 | -1.47% | 272.11万 | 0.33% | -2295.28万 | -2.75% | 3252.18万 | 3.90% |